nach oben

Erschienen in:

01.06.2012 | Preclinical Study

Differential oxidative status and immune characterization of the early and advanced stages of human breast cancer

verfasst von: C. Panis, V. J. Victorino, A. C. S. A. Herrera, L. F. Freitas, T. De Rossi, F. C. Campos, A. N. Colado Simão, D. S. Barbosa, P. Pinge-Filho, R. Cecchini, A. L. Cecchini

Erschienen in: Breast Cancer Research and Treatment | Ausgabe 3/2012

Einloggen, um Zugang zu erhalten

Abstract

Breast cancer is the malignant neoplasia with the highest incidence in women worldwide. Chronic oxidative stress and inflammation have been indicated as major mediators during carcinogenesis and cancer progression. Human studies have not considered the complexity of tumor biology during the stages of cancer advance, limiting their clinical application. The purpose of this study was to characterize systemic oxidative stress and immune response parameters in early (ED; TNM I and II) and advanced disease (AD; TNM III and IV) of patients diagnosed with infiltrative ductal carcinoma breast cancer. Oxidative stress parameters were evaluated by plasmatic lipoperoxidation, carbonyl content, thiobarbituric reactive substances (TBARS), nitric oxide levels (NO), total radical antioxidant parameter (TRAP), superoxide dismutase, and catalase activities and GSH levels. Immune evaluation was determined by TNF-α, IL-1β, IL-12, and IL-10 levels and leukocytes oxidative burst evaluation by chemiluminescence. Tissue damage analysis included heart (total CK and CKMB), liver (AST, ALT, GGT), and renal (creatinine, urea, and uric acid) plasmatic markers. C-reactive protein (CRP) and iron metabolism were also evaluated. Analysis of the results verified different oxidative stress statuses occur at distinct cancer stages. ED was characterized by reduction in catalase, 8-isoprostanes, and GSH levels, with enhanced lipid peroxidation and TBARS levels. AD exhibited more pronounced oxidative status, with reduction in catalase activity and TRAP, intense lipid peroxidation and high levels of NO, TBARs, and carbonyl content. ED patients presented a Th2 immune pattern, while AD exhibited Th1 status. CRP levels and ferritin were increased in both stages of disease. Leukocytes burst impairment was observed in both the groups. Plasma iron levels were significantly elevated in AD. The data obtained indicated that oxidative stress enhancement and immune response impairment may be necessary to ensure cancer progression to advanced stages and may result from both host and tumor inflammatory mediators.

Boyle P, Howell A (2010) The globalization of breast cancer. Breast Cancer Res 12(Suppl 4):S7PubMedCrossRef

Howell A (2010) The emerging breast cancer epidemic: early diagnosis and treatment. Breast Cancer Res 12(Suupl 4):S10PubMedCrossRef

Gago-Dominguez M, Jiang X, Castelao E (2007) Lipid peroxidation, oxidative stress genes and dietary factors in breast cancer protection: a hypothesis. Breast Cancer Res 9:201PubMedCrossRef

Bae YJ, Yeon JY, Sung CJ, Kim HS, Sumg MK (2009) Dietary intake and serum levels of iron in relation to oxidative stress in breast cancer patients. J Clin Biochem Nutr 45:355–360PubMedCrossRef

Tas F, Hansel H, Belce A, Ilvan F, Argon A, Camlica H, Topuz E (2005) Oxidative stress in breast cancer. Med Oncol 22(1):11–15PubMedCrossRef

Wang M, Dhingra K, Hittelman WN, Liehr JG, De Andrade M, Li D (1996) Lipid peroxidation-induced putative malondialdehyde-DNA adducts in human breast tissues. Cancer Epidemiol Biom Prev 5(9):705–710

Gonenç A, Erten D, Aslan S, Akinci M, Simsek B, Torun M (2006) Lipid peroxidation and antioxidant status in blood and tissue of malignant breast tumor and benign breast disease. Cell Biol Int 30(4):376–380PubMedCrossRef

Mannello F, Tonti GAM, Pagliarani S, Benedetti S, Canestrari F, Zhu W, Qin W, Sauter ER (2007) The 8-epimer of prostaglandin F2α, a marker of lipid peroxidation and oxidative stress, is decreased in the nipple aspirate fluid of women with breast cancer. Int J Cancer 120(9):1971–1976PubMedCrossRef

Feger F, Ferry-Dumazet H, Matsuda MM, Bordenave J, Dupouy M, Nussler AK, Arock M, Devevey L, Nafziger J, Guilosson JJ, Reiffers J, Mossalayi MD (2001) Role of iron in tumor cell protection from the pro-apoptotic effect of nitric oxide. Cancer Res 61:5289–5294PubMed

10.

Kohgo Y, Ikuta K, Ohtake T, Torimoto Y, Kato J (2008) Body iron metabolism and pathophysiology of iron overload. Int J Hematol 88:7–15PubMedCrossRef

11.

Mannello F, Tonti GA, Simone P, Ligi D, Medda V (2011) Iron-binding proteins and C-reactive protein in nipple aspirate fluids: role of iron-driven inflammation in breast cancer environment? Am J Transl Res 3(1):100–113

12.

DeNardo DG, Coussens LM (2007) Inflammation and breast cancer. Balancing immune response: crosstalk between adaptative and innate immune cells during breast cancer progression. Breast Cancer Res 9:212PubMedCrossRef

13.

Repetto M, Reides C, Carretero MLG, Costa M, Griemberg G, Llesuy S (1996) Oxidative stress in blood of HIV infected patients. Clin Chim Acta 225:107–117CrossRef

14.

Aebi H (1984) Catalase in vitro. Methods Enzymol 105:121–126PubMedCrossRef

15.

Marklund S, Marklund G (1974) Involvement of the superoxide anion radical in the autoxidation of pyrogallol and a convenient assay for superoxide dismutase. Eur J Biochem 47:469–474PubMedCrossRef

16.

Sedlak J, Lindsay RH (1968) Estimation of total, protein-bound, and nonprotein sulfhydryl groups in tissue with Ellman’s reagent. Anal Biochem 25:192–205PubMedCrossRef

17.

Gonzales-Flecha B, Llesuy S, Boveris A (1991) Hydroperoxide-initiated chemiluminescence: an assay for oxidative stress in biopsies of heart, liver and muscle. Free Rad Biol Med 10:93–100CrossRef

18.

Panis C, Mazzuco TL, Costa CZF, Victorino VJ, Tatakihara VLH, Yamauchi LM, Yamada-Ogatta SF, Cecchini R, Pinge-Filho P (2011) Trypanosoma cruzi: effect of the absence of 5-lipoxygenase (5-LO)-derived leukotrienes on levels of cytokines, nitric oxide and iNOS expression in cardiac tissue in the acute phase of infection in mice. Exp Parasitol 127:58–65PubMedCrossRef

19.

Oliveira JA, Cecchini R (2000) Oxidative stress of liver in hamsters infected with Leishmania (L.) chagasic. J Parasitol 86(5):1067–1072PubMedCrossRef

20.

Panis C, Herrera AC, Victorino VJ, Campos FC, Freitas LF, De Rossi T, Colado Simão AN, Cecchini AL, Cecchini R. Oxidative stress and hematological profiles of advanced breast cancer patients subjected to paclitaxel or doxorubicin chemotherapy. Breast Cancer Res Treat. 2011 Aug 3. [Epub ahead of print]

21.

Miller GL (1959) Protein determination for large numbers of samples. Anal Chem 31:964CrossRef

22.

Kukovetz EM, Bratschitcch G, Hofer HP, Egger G, Schaur RJ (1997) Influence of age on the release of reactive oxygen species by phagocytes as measured by a whole blood chemiluminescence assay. Free Rad Biol Med 22(3):433–438PubMedCrossRef

23.

Rajneesh CP, Manimaran A, Sasikala KR, Adaikappan P (2008) Lipid peroxidation and antioxidant status in patients with breast cancer. Singap Med J 49(8):640–643

24.

Diploc AT, Rice-Evans CA, Burdon RH (1994) Is there a significant role for lipid peroxidation in the causation of malignancy and for antioxidants in cancer prevention? Cancer Res 54:1952s–1956s

25.

Beevi SSS, Rasheed AMH, Geetha A (2004) Evaluation of oxidative stress and nitric oxide levels in patients with oral cavity cancer. Jpn J Clin Oncol 34(7):379–385PubMedCrossRef

26.

Sakuma S, Sumi H, Kohda T, Arakawa Y, Fujimoto Y (2009) Effects of lipid peroxidation-derived products on the growth of human colorectal cancer cell line HT-29. J Clin Biochem Nutr 45:171–177PubMedCrossRef

27.

Ahmad R, Tripathi AK, Tripathi P, Singh R, Singh S, Singh RK (2010) Studies on lipid peroxidation and non-enzymatic antioxidant status as indices of oxidative stress in patients with chronic myeloid leukemia. Singap Med J 51(2):110–115

28.

Halliwell B, Gutteridge JMC (2007) Free radicals in biology and medicine, 4th edn. Oxford University, New York

29.

Ravuri C, Svineng G, Pankiv S, Huseby NE (2011) Endogenous production of reactive oxygen species by the NADPH oxidase complexes is a determinant of gamma-glutamyl transferase expression. Free Rad Res 45(5):600–610CrossRef

30.

Franco R, Cidlowski JA (2009) Apoptosis and glutathione: beyond an antioxidant. Cell Death Diff 16:1303–1314CrossRef

31.

Clancy T, Pedicini M, Castiglione F, Santoni D, Nygaard V, Lavelle TJ, Benson M, Hovig E (2011) Immunological network signatures of cancer progression and survival. BMC Med Genomics 4(1):28PubMedCrossRef

32.

Gomes AQ, Correia DV, Silva-Santos B (2007) Non-classical major histocompatibility complex proteins as determinants of tumor surveillance. EMBO rep 8:1024–1030PubMedCrossRef

33.

Stewart TJ, Smyth MJ (2011) Improving cancer immunotherapy by targeting tumor-induced immune suppression. Cancer Metastasis Rev 30(1):125–140PubMedCrossRef

34.

Negre-Salvayre A, Coatrieux C, Ingueneau C, Salvayre R (2008) Advanced lipid peroxidation end products in oxidative damage to proteins. Potential role in diseases and therapeutic prospects for the inhibitors. Brit J Pharmacol 153:6–20CrossRef

35.

Badid N, Ahmed FZ, Merzouk H, Belbraouet S, Mokhtari N, Merzouk SA, Benhabib R, Hamzaoui D, Narce M (2010) Oxidant/antioxidant status, lipids and hormonal profile in overweight women with breast cancer. Pathol Oncol Res 16(2):159–167PubMedCrossRef

36.

Mannello F, Tonti GA, Medda V (2009) Protein oxidation in breast microenvironment: nipple aspirate fluid collected from breast cancer women contains increased protein carbonyl concentration. Cell Oncol 31(5):383–392PubMed

37.

Bierie B, Moses HL (2009) Gain or loss of TGF-β signalling in mammary carcinoma cells can promote metastasis. Cell Cycle 8(20):319–3327CrossRef

38.

DeMichelle A, Gray R, Horn M, Chen J, Aplenc R, Vaughan WP, Tallman MS (2009) Host genetic variants in the interleuin-6 promoter predict poor outcome in patients with estrogen-receptor-positive, node-positive breast cancer. Cancer Res 69(10):4184–4191CrossRef

39.

Pelekanou V, Kampa M, Kafousi M, Darivianaki K, Sanidas E, Tsiftisis DD, Stathopoulos EM, Tsapis A, Castanas E (2008) Expression of TNF-superfamily members BAFF and APRIL in breast cancer: immunohistochemical study I 52 invasive ductal carcinomas. BMC Cancer 8:76–85PubMedCrossRef

40.

Halliwell B (2007) Oxidative stress and cancer: have we moved forward? Biochem J 401(1):1–11PubMedCrossRef

41.

Galon J, Costes A, Sanchez-Cabo F, Kirilovzki A, Mlecnick B, Lagorce-Pages C, Tosolini M, Camus M, Berger A, Wind P, Zinzindohoue F, Bruneval P, Cugnenc PR, Trajanoski Z, Fridman WH, Pages F (2006) Type, density and location of immune cells within human colorectal tumors predict clinical outcome. Science 313:1960–1964PubMedCrossRef

42.

Leek RD, Landers R, Fox SB, Ng F, Harris AL, Lewis CE (1998) Association of tumor necrosis factor alpha and its receptors with thymidine phosphorylase expression in invasive breast carcinoma. Br J Cancer 77(12):2246–2251PubMedCrossRef

43.

Reed JR, Leon RP, Hall MK, Schwertfeger KL (2009) Interleukin 1-beta and fibroblast growth factor receptor 1 cooperate to induce cyclooxygenase-2 during early mammary tumorigenesis. Breast Cancer Res 11:R21PubMedCrossRef

44.

Nakamura Y, Yasuoka H, Tsujimoto M, Yoshidome K, Nakahara M, Nakao K, Nakamura M, Kakudo K (2006) Nitric oxide in breast cancer: induction of vascular endothelial growth factor-C and correlation with metastasis and poor prognosis. Clin Cancer Res 12(4):1201–1207PubMedCrossRef

45.

Menconi E, Barzi A, Greco M, Caprino MC, De Vecchis L, Muggia F (1979) Immunological profile of breast cancer patients in early and advanced disease. Experientia 35(6):820–822PubMedCrossRef

46.

Mandeville R, Lamoureux G, Legault-Poisson S, Poisson R (1982) Biological markers and breast cancer. A multiparametric study. II: depressed immune competence. Cancer 50:1280–1288PubMedCrossRef

47.

Merendino RA, Gangemi S, Misefari A, Arena A, Capozza AB, Chillemi S, Purello D’Ambrosio F (1999) Interleukin-12 and interleuki-10 production by mononuclear phagocytic cells from breast cancer patients. Immunol Lett 68:355–358PubMedCrossRef

48.

Caras I, Grigorescu A, Stavaru C, Radu DL, Mogos I, Szegli G, Salageanu A (2004) Evidence for immune defects in breast and lung cancer patients. Cancer Immunol Imunnother 53:1146–1152CrossRef

49.

Gruber IV, El Yousfi S, Durr-Storzer S, Wallwiener D, Solomayer EF, Fehm T (2008) Down-regulation of CD28, TCR-zeta and up-regulation of FAS in peripheral cytotoxic T cells of primary breast cancer patients. Anticancer Res 28(2):779–784PubMed

50.

Gutteridge JMC (1984) Ferrous-ion EDTA-stimulated phospholipid peroxidation. Biochem J 224:697–701PubMed

51.

Bacon BR, Tavill AS, Brittenham TM, Park CH (1983) Hepatic lipid peroxidation in vivo in rats with chronic iron overload. J Clin Invest 71:429–439PubMedCrossRef

52.

Joo NS, Kim SM, Jung YS, Kim KM (2009) Hair iron and other minerals’ level in breast cancer patients. Biol Trace Elem Res 129:28–35PubMedCrossRef

53.

Jian J, Yang Q, Dai J, Eckard J, Axelrod D, Smith J, Huang X (2011) Effects of iron deficiency and iron overload on angiogenesis and oxidative stress—a potential dual role for iron in breast cancer. Free Rad Biol Med 50:841–847PubMedCrossRef

54.

Moore AB, Shannon J, Chen C, Lampe JW, Ray RM, Lewis SK, Lin M, Stalsberg H, Thomas DB (2009) Dietary and stored iron as predictors of breast cancer risk: a nested case-control study in Shangai. Int J Cancer 125(5):1110–1117PubMedCrossRef

55.

Wink DA, Vodovotz Y, Laval J, Laval F, Dewhirst MW, Mitchell JB (1998) The multifaceted roles of nitric oxide in cancer. Carcinogenesis 19(5):711–721PubMedCrossRef

Titel: Differential oxidative status and immune characterization of the early and advanced stages of human breast cancer
verfasst von: C. Panis
V. J. Victorino
A. C. S. A. Herrera
L. F. Freitas
T. De Rossi
F. C. Campos
A. N. Colado Simão
D. S. Barbosa
P. Pinge-Filho
R. Cecchini
A. L. Cecchini
Publikationsdatum: 01.06.2012
Verlag: Springer US
Erschienen in: Breast Cancer Research and Treatment / Ausgabe 3/2012
Print ISSN: 0167-6806
Elektronische ISSN: 1573-7217
DOI: https://doi.org/10.1007/s10549-011-1851-1

Neu im Fachgebiet Onkologie

23.04.2024 | Medikamente in Schwangerschaft und Stillzeit | Nachrichten

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Differential oxidative status and immune characterization of the early and advanced stages of human breast cancer

Abstract

Neu im Fachgebiet Onkologie

ICI-Therapie in der Schwangerschaft wird gut toleriert

Krebspatienten impfen: Was? Wen? Und wann nicht?

Müde im Alter? Auch an die Nebenniere denken

Stufenschema weist Prostatakarzinom zuverlässig nach

Update Onkologie

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 3/2012

A CD44−/CD24+ phenotype is a poor prognostic marker in early invasive breast cancer

Family history and risk of breast cancer: nurses’ health study

Association of CD27 and CD70 gene polymorphisms with risk of sporadic breast cancer in Chinese women in Heilongjiang Province

25-Hydroxy vitamin-D, obesity, and associated variables as predictors of breast cancer risk and tamoxifen benefit in NSABP-P1

Basal-like Breast cancer DNA copy number losses identify genes involved in genomic instability, response to therapy, and patient survival

Recommendations for antiresorptive therapy in postmenopausal patients with breast cancer: Marburg AIBL Guideline Evaluation Study (MAGES)

Neu im Fachgebiet Onkologie

ICI-Therapie in der Schwangerschaft wird gut toleriert

Krebspatienten impfen: Was? Wen? Und wann nicht?

Müde im Alter? Auch an die Nebenniere denken

Stufenschema weist Prostatakarzinom zuverlässig nach

Update Onkologie